A study conducted at the London School of Hygiene & Tropical Medicine suggests that higher intake of antioxidants is beneficial for eye health. The conclusion is based on the finding that a combination of exposure to blue light and lower plasma levels of antioxidants can cause age-related macular degeneration (AMD). Blue light was found to be damaging for retina. Doctors recommended the use of ocular protection and following of dietary instructions.

A study published in the Archives of Ophthalmology has indicated an association between women who take postmenopausal hormones and the risk of developing age-related macular degeneration (AMD), which is the chief cause of blindness and loss of vision among older adults. According to the study led by Diane Feskanich, for women who had taken oral contraceptives, postmenopausal hormones reduced the risk of progression to advanced stages of AMD.

Data from a Phase I study of sirolimus (rapamycin), MacuSight’s treatment for wet age-related macular edema (AMD), suggests its safety in all doses tested in two ways of administration. The study was randomized and open label and there was no indication of increased intraocular pressure, inflammatory response to treatment or indication of progression of cataracts. Patients reported an improvement in visual acuity, despite extended exposure to the disease.